The pharmaceutical cannabis market, valued at $12.68 billion in 2023, is growing rapidly due to expanding applications in chronic pain, mental health, and cancer treatment. Expected to reach $53.88 billion by 2030, this growth, at a 22.9% CAGR, is fuelled by increased acceptance, regulatory shifts, and advances in cannabis-based research and delivery methods.